MEI Pharma Announces Planned Departure Of Chief Financial Officer Brian Drazba And Appointment Of Justin File As Successor
Portfolio Pulse from Benzinga Newsdesk
MEI Pharma announces the planned departure of CFO Brian Drazba by September 1, 2023, and the appointment of Justin File as his successor. File has 30 years of experience in accounting and finance, and previously served as CFO of Evofem Biosciences.
June 13, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
MEI Pharma's CFO Brian Drazba will depart by September 1, 2023, and Justin File will succeed him. File has extensive experience in accounting and finance, including as CFO of Evofem Biosciences.
The departure of a CFO and the appointment of a successor can have an impact on a company's stock price. However, since Justin File has extensive experience in the field, including as CFO of Evofem Biosciences, the impact on MEIP's stock price is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100